FormWeb • citalopram

Oregon Department of Corrections

Approved Formulary

Webpage Links

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

citalopram

citalopram

Earned In-Cell If AIC demonstrates adherence to proper regimen for 60 or more days
Exceptions / Designators Maximum formulary dose is 40mg per day. Any dose exceeding 40mg requires TLoC approval.

Brand names: CELEXA, Citalopram Hydrobromide

Form	Strength
TABLET, ORAL	10 mg; 20 mg; 40 mg

Additional Information:

COMBINED USE OF ANTIDEPRESSANTS BY BHS AND MEDICAL

JUNE 2022 P&T MINUTES

APRIL 2020 P&T MINUTES

JANUARY 2018 P&T MINUTES

JULY 2014 P&T MINUTES

JUNE 2014 P&T MINUTES

SEPTEMBER 2013 P&T MINUTES

NOVEMBER 2011 P&T MINUTES

OCTOBER 2011 P&T MINUTES

SEPTEMBER 2011 P&T MINUTES

Last updated: Jul. 21, 2022

Black Box Warning: Suicidal Thoughts and Behaviors
FDA Drug Safety: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.